One goal of The North American Menopause Society (NAMS) is to develop position statements and other reports about clinical issues pertinent to women at midlife and beyond. Originally published in the Society's journal Menopause, these statements are available below for viewing and downloading free of charge. They are also available from NAMS in hard copy for a modest fee by using this Order Form.
ORDER FORM Some statements provide accompanying PowerPoint slides summarizing the paper’s contents—available free of charge only to members.
NAMS Statements and Other Reports
Workshop on normal reference ranges for estradiol in postmenopausal women, September 2019, Chicago, Illinois
NAMS Commentary on low-dose vaginal estrogen therapy labeling
NAMS 2018 Utian Translational Science Symposium report: New Therapies for Leiomyomas: When Surgery May Not Be the Best Option
Guidelines for the Evaluation and Treatment of Perimenopausal Depression
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women’s Sexual Health